Non-coding RNAs in Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Neurobiology

• Publication date

  2012-10-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12035-012-8359-5PMID 23054683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Accelerated Regions : plus rapide dans l ’ humain mais conservé ailleurs An RNA gene expressed during cortical development evolved rapidly in humans

  2014cited by this paper
• MicroRNAs and the Regulation of Tau Metabolism

  2012cited by this paper
• MicroRNAs: Novel Regulators of Oligodendrocyte Differentiation and Potential Therapeutic Targets in Demyelination-Related Diseases

  2012cited by this paper
• Evidence of early involvement of apoptosis inducing factor-induced neuronal death in Alzheimer brain

  2012cited by this paper
• The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.

  2012cited by this paper
• MicroRNAs in neurodegenerative diseases and their therapeutic potential.

  2012cited by this paper
• Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.

  2012cited by this paper
• The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?

  2012influential reference
• Deep sequencing analysis of the developing mouse brain reveals a novel microRNA

  2011cited by this paper
• APOE and Alzheimer disease: a major gene with semi-dominant inheritance

  2011cited by this paper
• MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU.1 pathway

  2011cited by this paper
• Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

  2011cited by this paper
• In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs

  2011cited by this paper
• MicroRNAs and Alzheimer's Disease Mouse Models: Current Insights and Future Research Avenues

  2011cited by this paper
• MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed.

  2011influential reference
• Sirt1 and mir‐9 expression is regulated during glucose‐stimulated insulin secretion in pancreatic β‐islets

  2011influential reference
• O4‐06‐06: 48‐week efficacy and tolerability of treatment with SB‐742457, a novel 5HT6 receptor antagonist, when added on to donepezil in subjects with mild‐to‐moderate Alzheimer's disease (AD)

  2011cited by this paper
• miR-29c regulates BACE1 protein expression.

  2011influential reference
• microRNAs in neurons: manifold regulatory roles at the synapse.

  2011cited by this paper
• A comprehensive genetic association study of Alzheimer disease in African Americans.

  2011cited by this paper
• Role of hnRNP-A1 and miR-590-3p in Neuronal Death: Genetics and Expression Analysis in Patients with Alzheimer Disease and Frontotemporal Lobar Degeneration

  2011cited by this paper
• 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease.

  2011cited by this paper
• MicroRNA-137/181c Regulates Serine Palmitoyltransferase and In Turn Amyloid β, Novel Targets in Sporadic Alzheimer's Disease

  2011influential reference
• Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter

  2011influential reference
• Non-coding RNA networks underlying cognitive disorders across the lifespan.

  2011cited by this paper
• miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis.

  2011cited by this paper
• The central role of RNA in human development and cognition

  2011cited by this paper
• A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing.

  2011cited by this paper
• microRNA‐34c is a novel target to treat dementias

  2011cited by this paper
• Computational methodologies for studying non-coding RNAs relevant to central nervous system function and dysfunction.

  2010cited by this paper
• Context-dependent functions of specific microRNAs in neuronal development

  2010cited by this paper
• MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons*

  2010cited by this paper
• Comprehensive survey of human brain microRNA by deep sequencing

  2010cited by this paper
• The genetics of Alzheimer disease: back to the future.

  2010cited by this paper
• Inflammation in Neurological Disorders: A Help or a Hindrance?

  2010cited by this paper
• Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

  2010cited by this paper
• Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β

  2010cited by this paper
• Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model

  2010cited by this paper
• The Drosophila miR-310 cluster negatively regulates synaptic strength at the neuromuscular junction.

  2010cited by this paper
• Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

  2010cited by this paper
• Active Immunization with Amyloid-β 1–42 Impairs Memory Performance through TLR2/4-Dependent Activation of the Innate Immune System

  2010cited by this paper
• Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration.

  2010cited by this paper
• Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA Regulation

  2010cited by this paper
• Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases

  2010cited by this paper
• miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease.

  2010cited by this paper
• Neuroimmunomodulation in the Pathogenesis of Alzheimer’s Disease

  2010cited by this paper
• The plasticity of the mammalian transcriptome.

  2010cited by this paper
• Epigenetic changes and non-coding expanded repeats.

  2010influential reference
• Aberrant microRNA expression in the brains of neurodegenerative diseases: miR‐29a decreased in Alzheimer disease brains targets neurone navigator 3

  2010influential reference
• Inflammation and Alzheimer’s disease

  2010cited by this paper
• APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease

  2009cited by this paper
• Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex.

  2009cited by this paper
• Long non-coding RNAs: insights into functions

  2009cited by this paper
• The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule

  2009cited by this paper
• miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.

  2009cited by this paper
• MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.

  2009influential reference
• Pervasive transcription constitutes a new level of eukaryotic genome regulation

  2009cited by this paper
• MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1*

  2009influential reference
• Classification and basic pathology of Alzheimer disease

  2009cited by this paper
• Evolution and functions of long noncoding RNAs.

  2009cited by this paper
• Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease

  2009influential reference
• deepBase: a database for deeply annotating and mining deep sequencing data

  2009cited by this paper
• Divergent intracellular pathways regulate interleukin‐1β‐induced miR‐146a and miR‐146b expression and chemokine release in human alveolar epithelial cells

  2009cited by this paper
• A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis

  2009cited by this paper
• The long and the short of noncoding RNAs.

  2009cited by this paper
• Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase

  2008cited by this paper
• An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells*

  2008influential reference
• Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

  2008influential reference
• The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1

  2008cited by this paper
• The impact of microRNAs on protein output

  2008cited by this paper
• Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

  2008influential reference
• TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

  2008cited by this paper
• Noncoding RNAs in Long-Term Memory Formation

  2008cited by this paper
• NRED: a database of long noncoding RNA expression

  2008cited by this paper
• Widespread changes in protein synthesis induced by microRNAs

  2008cited by this paper
• Targeting miRNAs in Alzheimer’s disease

  2008cited by this paper
• A miRNA Signature of Prion Induced Neurodegeneration

  2008cited by this paper
• The APP family of proteins: similarities and differences.

  2007cited by this paper
• RNA Maps Reveal New RNA Classes and a Possible Function for Pervasive Transcription

  2007cited by this paper
• MicroRNA Expression in Alzheimer Blood Mononuclear Cells

  2007cited by this paper
• Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus

  2007influential reference
• Dendritic BC200 RNA in aging and in Alzheimer's disease

  2007cited by this paper
• Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

  2007cited by this paper
• Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease.

  2007cited by this paper
• Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

  2007cited by this paper
• Non-coding RNA.

  2006cited by this paper
• MicroRNA pathways modulate polyglutamine-induced neurodegeneration.

  2006cited by this paper
• Noncoding RNAs in the mammalian central nervous system.

  2006cited by this paper
• A network dysfunction perspective on neurodegenerative diseases

  2006cited by this paper
• NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

  2006cited by this paper
• A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes.

  2006cited by this paper
• Waste not, want not--transcript excess in multicellular eukaryotes.

  2005cited by this paper
• Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model

  2005cited by this paper
• Small RNAs in Human Brain Development and Disorders

  2005cited by this paper
• Biochemical specialization within Arabidopsis RNA silencing pathways.

  2005cited by this paper
• RNAi: the nuts and bolts of the RISC machine.

  2005cited by this paper
• MinireviewThe Elegance of the MicroRNAs : A Neuronal Perspective

  2005cited by this paper
• Role reversal: the regulation of neuronal gene expression by microRNAs.

  2005cited by this paper
• Ribo-gnome: The Big World of Small RNAs

  2005cited by this paper
• Small regulatory RNAs in mammals.

  2005cited by this paper

• Anti-Amyloidogenic, Anti-Inflammatory, and Antioxidant Effects of a Lyposomal Form of Curcumin and MicroRNA-101 in the Experimental Model of Alzheimer’s Disease in Rats

  2026cites this paper
• Whole Transcriptome RNA-Seq Reveals Drivers of Pathological Dysfunction in a Transgenic Model of Alzheimer’s Disease

  2025cites this paper
• Epigenetic Editing in Neurological and Neuropsychiatric Disorders: Pioneering Next-Gen Therapeutics for Precision Gene Control

  2025cites this paper
• Research Progress on Epigenetic Regulation in Neurodegenerative Diseases

  2025cites this paper
• Rewired m6A of promoter antisense RNAs in Alzheimer’s disease regulates neuronal genes in 3D nucleome

  2025cites this paper
• Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil

  2025cites this paper
• PIWI-Interacting RNAs: A Pivotal Regulator in Neurological Development and Disease

  2024cites this paper
• A nested case-control study of circular ribonucleic acid expression profiles in the peripheral blood of pregnant women with pre-eclampsia

  2024cites this paper
• Identification of pathological pathways centered on circRNA dysregulation in association with irreversible progression of Alzheimer’s disease

  2024cites this paper
• Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives

  2024cites this paper
• A brief review of noncoding RNA

  2024cites this paper
• miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia

  2024cites this paper
• Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease

  2024influential citation
• The roles of long non-coding RNAs in Alzheimer's disease diagnosis, treatment, and their involvement in Alzheimer's disease immune responses

  2024cites this paper
• Long noncoding RNA HIKER regulates erythropoiesis in Monge’s disease via CSNK2B

  2023cites this paper
• Optimal decision-making in high-throughput virtual screening pipelines

  2023cites this paper
• miR-429-3p mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of Alzheimer's disease

  2023cites this paper
• Development of Computational Correlations among Known Drug Scaffolds and their Target-Specific Non-Coding RNA Scaffolds of Alzheimer's Disease.

  2023cites this paper
• Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer’s Disease

  2023cites this paper
• Alzheimer’s Disease-Related Epigenetic Changes: Novel Therapeutic Targets

  2023cites this paper
• Can Genetic Markers Predict the Sporadic Form of Alzheimer’s Disease? An Updated Review on Genetic Peripheral Markers

  2023cites this paper
• Predicting potential lncRNA biomarkers for lung cancer and neuroblastoma based on an ensemble of a deep neural network and LightGBM

  2023cites this paper
• Circadian rhythm sleep disorders and time-of-day-dependent memory deficiency in Presenilin1/2 conditional knockout mice with long noncoding RNA expression profiling changes.

  2023cites this paper
• The Role of miR-128 in Neurodegenerative Diseases

  2023cites this paper
• A Candidate microRNA Profile for Early Diagnosis of Sporadic Alzheimer’s Disease

  2023cites this paper
• Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• Contrastive Self-Supervised Learning for Predicting Disease-RNA Associations

  2022cites this paper
• Emerging Therapeutics Agents and Recent Advances in Drug Repurposing for Alzheimer's Disease.

  2022cites this paper
• Augmentation of 2-arachidonoylglycerol signaling in astrocytes maintains synaptic functionality by regulation of miRNA-30b.

  2022cites this paper
• Editorial: Non-coding RNA in Alzheimer's pathology and diagnosis

  2022cites this paper
• Genome‐wide profiling of circulatory microRNAs associated with cognition and dementia

  2022cites this paper
• The role of LncRNAs in the development of cataracts

  2022cites this paper
• Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis

  2022cites this paper
• Blood circulating miR-28-5p and let-7d-5p associate with premature ageing in Down Syndrome.

  2022cites this paper
• Circ-HUWE1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury in SK-N-SH Cells via miR-433-3p Release-Mediated FGF7 Downregulation

  2022cites this paper
• PRIP: A Protein-RNA Interface Predictor Based on Semantics of Sequences

  2022cites this paper
• Optimal Decision Making in High-Throughput Virtual Screening Pipelines

  2021cites this paper
• Optimal Decision Making in High-Throughput Virtual Screening Pipelines

  2021cites this paper
• Recent Developments in Delivery of MicroRNAs Utilizing Nanosystems for Metabolic Syndrome Therapy

  2021cites this paper
• Effects of the lncRNA ENST00000623984 on colon cancer and the biological characteristics of colon cancer cells

  2021cites this paper
• BiGAN: LncRNA-disease association prediction based on bidirectional generative adversarial network

  2021cites this paper
• Dysregulation of long non‐coding RNAs and their mechanisms in Huntington's disease

  2021cites this paper
• Construction of Long Noncoding RNA-Associated ceRNA Networks Reveals Potential Biomarkers in Alzheimer’s Disease

  2021cites this paper
• The Protective Effect of Picroside II on Isoflurane-Induced Neuronal Injury in Rats via Downregulating miR-195

  2021cites this paper
• miRNAs as Therapeutic Tools in Alzheimer’s Disease

  2021cites this paper
• Discoveries of the specific expression of lncRNAs and mRNAs in hippocampus of rats after traumatic brain injury.

  2021cites this paper
• Aberrant Expression Profiles of lncRNAs and Their Associated Nearby Coding Genes in the Hippocampus of the SAMP8 Mouse Model with AD

  2020cites this paper
• Genome wide analysis of gene expression changes in skin from patients with type 2 diabetes

  2020cites this paper
• Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer’s Disease Mice

  2020cites this paper
• RNA sequencing and transcriptome analysis

  2020cites this paper
• Characterization of a G-Quadruplex Structure in Pre-miRNA-1229 and in Its Alzheimer’s Disease-Associated Variant rs2291418: Implications for miRNA-1229 Maturation

  2020cites this paper
• Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein

  2020cites this paper
• Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?

  2020cites this paper
• Postnatal toxicant exposure in 3xTgAD mice promotes gene x environment-related early alterations to neuroimmune epigenetic profiles

  2020cites this paper
• Succinate Dehydrogenase and Ribonucleic Acid Networks in Cancer and Other Diseases

  2020cites this paper
• Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites

  2020cites this paper
• Effect of hsa_circ_RNA0023397 regulation of miR-106b expression on proliferation and apoptosis of esophageal cancer cells.

  2020cites this paper
• MicroRNA-138 promotes neuroblastoma SH-SY5Y cell apoptosis by directly targeting DEK in Alzheimer’s disease cell model

  2020cites this paper
• MicroRNA miR-212 regulates PDCD4 to attenuate Aβ25–35-induced neurotoxicity via PI3K/AKT signaling pathway in Alzheimer’s disease

  2020cites this paper
• Transcriptomics in Alzheimer’s Disease: Aspects and Challenges

  2020cites this paper
• Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer's disease through inactivating the PI3K/Akt signaling pathway

  2019cites this paper
• microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.

  2019cites this paper
• Relationship between long non-coding RNAs and Alzheimer's disease: a systematic review.

  2019cites this paper
• Systems biology and gene networks in Alzheimer's disease

  2019cites this paper
• New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases

  2019cites this paper
• Long noncoding RNA X-inactive specific transcript as a prognostic factor in cancer patients

  2019cites this paper
• Expression signatures of long non-coding RNA and mRNA in human traumatic brain injury

  2019cites this paper
• Long Non-Coding RNAs in Multiple Myeloma

  2019cites this paper
• Upregulated circ RNA hsa_circ_0000337 promotes cell proliferation, migration, and invasion of esophageal squamous cell carcinoma

  2019cites this paper
• Down Syndrome, Ageing and Epigenetics.

  2019cites this paper
• BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs.

  2019cites this paper
• Upregulation of microRNA‐196a improves cognitive impairment and alleviates neuronal damage in hippocampus tissues of Alzheimer's disease through downregulating LRIG3 expression

  2019cites this paper
• Klotho Ameliorates Cellular Inflammation via Suppression of Cytokine Release and Upregulation of miR-29a in the PBMCs of Diagnosed Alzheimer’s Disease Patients

  2019cites this paper
• miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease.

  2019cites this paper
• Alzheimer's Disease: key developments support promising perspectives for therapy.

  2019cites this paper
• MicroRNA delivery through nanoparticles

  2019cites this paper
• Weighted gene co‐expression network analysis to explore the mechanism of heroin addiction in human nucleus accumbens

  2019cites this paper
• Whole-Transcriptome Analysis of APP/PS1 Mouse Brain and Identification of circRNA-miRNA-mRNA Networks to Investigate AD Pathogenesis

  2019cites this paper
• Long Non-coding RNAs in Peripheral Blood Mononuclear Cells Associated with Alzheimer Disease

  2019influential citation
• The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.

  2018cites this paper
• Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy

  2018cites this paper
• A novel mechanism of synaptic and cognitive impairments mediated via microRNA-30b in Alzheimer's disease

  2018cites this paper
• Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer’s Disease

  2018cites this paper
• miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition.

  2018cites this paper
• Recent Research Progress of Long Non-coding RNA

  2018cites this paper
• Aging and Alzheimer’s disease: Comparison and associations from molecular to system level

  2018cites this paper
• Étude du rôle physiologique et pathologique de la famille miR-132/212 dans le cerveau

  2018cites this paper
• HIF‐2α activated lncRNA NEAT1 promotes hepatocellular carcinoma cell invasion and metastasis by affecting the epithelial‐mesenchymal transition

  2018cites this paper
• THE ROLE OF CELLULAR AND EXOSOMAL NEURAL-DERIVED LONG NON CODING RNA (LNCRNA) IN MULTIPLE SCLEROSIS: POTENTIAL BIOMARKERS OF DISEASE SUSCEPTIBILITY AND PROGRESSION

  2018cites this paper
• Plasma Exosomal miRNA-122-5p and miR-300-3p as Potential Markers for Transient Ischaemic Attack in Rats

  2018cites this paper
• Knockdown of miR-429 Attenuates Aβ-Induced Neuronal Damage by Targeting SOX2 and BCL2 in Mouse Cortical Neurons

  2018cites this paper
• The Role of Long Noncoding RNAs in Central Nervous System and Neurodegenerative Diseases

  2018cites this paper
• Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease

  2018cites this paper
• NeurimmiRs and Postoperative Delirium in Elderly Patients Undergoing Total Hip/Knee Replacement: A Pilot Study

  2017cites this paper
• Overexpression of MicroRNA-145 Ameliorates Astrocyte Injury by Targeting Aquaporin 4 in Cerebral Ischemic Stroke

  2017cites this paper
• Upregulation of miR-130 b protects against cerebral ischemic injury by targeting water channel protein aquaporin 4 ( AQP 4 )

  2017cites this paper
• Expression Profiling of Long Noncoding RNA Splice Variants in Human Microvascular Endothelial Cells: Lipopolysaccharide Effects In Vitro

  2017cites this paper
• Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.

  2017cites this paper
• LncRna CPS1-IT1 Suppresses Cell Proliferation, Invasion and Metastasis in Colorectal Cancer

  2017cites this paper